Molecular Pharmacology
Researchers in the molecular pharmacology group utilise genomic, biophysical, biochemical and stem-cell technologies to identify disease processes and novel druggable targets for development of treatments for human disease. Our studies include modulation of post translational modification of cardiovascular disease proteins and determinants of vascular remodelling and repair.

Fernandez Caggiano Group
Cardiac metabolism and the mitochondrial pyruvate carrier's role in heart disease.

Campanella Group
Mitochondrial Cell Biology and Pharmacology Research.

Carvalho Group
Neuropsychology, Inflammation and cognitive function.

Charles Group
Redox sensing and signalling in cardiovascular and pulmonary systems.

Eaton Group
Redox signalling in cardiovascular health and disease.

Tinker Group
Cardiac arrhythmia and the role of ion channels in cardiac and vascular excitability.

Xiao Group
Stem cells and Cardiovascular disease.

Xu Group
Stem/progenitor cells in arteriosclerosis.